Icosavax, Inc.
Icosavax, Inc. (ICVX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ICVX · as of Jun 9, 2026
Key Statistics
Explore Icosavax, Inc. Data
icvx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 83.3%
The ICVX analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $27.00, representing +76.36% upside from the current price of $15.31.
Competitors & Peers
icvx competitorsICVX
ALBO
ASLN
CDMO
CMRX
EXAIStock Performance
Full HistoryAbout Icosavax, Inc.
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the com…
what is icosavax, inc. · icvx stock overview · icosavax, inc. company profile · who is icosavax, inc. ceo · icvx NASDAQ · icosavax, inc. headquarters · icosavax, inc. business segments
About Stock Overview & Key Data
Icosavax, Inc. (ICVX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 29, 2021. As of the latest trading session, ICVX stock price is $15.31, with a market capitalization of $769.0M. The stock has returned +138.85% over the past 12 months and -3.59% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Icosavax, Inc. stock is Buy, with an average 12-month price target of $27.00. In fiscal year 2022, Icosavax, Inc. reported revenue of $582000.00 and net income of -$88.5M. For detailed data — including Icosavax, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Icosavax, Inc. (ICVX) stock price is $15.31. The stock is traded on NASDAQ under the ticker symbol ICVX. The 52-week range is $4.75 – $16.11.